Dr. Richard F. Spaide, MD

Dr. Spaide practices at Vitreous Retina Macula Consultants of New York in New York, New York.

Dr. Spaide's NPI, 1730281957, was assigned on September 1, 2006. Dr. Spaide graduated from Jefferson Medical College of Thomas Jefferson University in 1981. Dr. Spaide holds New York license 164816-1.

Dr. Spaide's primary practice is Vitreous Retina Macula Consultants of New York, at 460 Park Ave, New York, NY 10022 in New York County. The practice phone is (212) 861-9797.

Dr. Spaide's primary practice is Vitreous Retina Macula Consultants of New York in New York, New York. Dr. Spaide is also affiliated with Lenox Hill Hospital. Dmand AI also links Dr. Spaide to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Spaide practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Spaide's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Spaide is licensed in New York.

CMS data shows 59,739 Medicare services from Dr. Spaide across 13 procedure codes in 2024, for 799 Medicare patients. Medicare paid $2,096,063 for them. Every service was in an office.

CMS counts 799 Medicare patients who saw Dr. Spaide in 2024. The largest group is 75 to 84, with 316 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Spaide's median patient age at 61, with 50% women.

In 2024, Dr. Spaide wrote 268 Medicare Part D claims for 102 patients. 64% of them were for generic drugs. CMS names the drug for 218 of them, across 11 drugs with 11 or more claims each, at $11,738 in total drug cost. In 2023, CMS named 91 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Spaide for performance year 2024, reported as part of a group. Dr. Spaide accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 15 procedures of cataract surgery by Dr. Spaide, more than 39% of the clinicians it reports for that procedure.

Dmand AI links 147 papers to Dr. Spaide, published from 2012 to 2025. 2020 was the busiest year, with 8. The most frequent topics are Tomography, Optical Coherence, Fluorescein Angiography and Choroid. Dr. Spaide has published most often in Retina. Dr. Spaide's most frequent co-authors are Christine Curcio, DO, Srinivas Reddy Sadda, MD and David Sarraf, MD.

CMS Open Payments shows 262 general payments to Dr. Spaide from 27 drug and device companies from 2016 to 2025. Royalties and licenses make up the largest share, 62% of the total. Topcon Medical Systems, Inc. paid the most, $1,617,989. It also lists 2 research payments totaling $23,842 from 2016 to 2022.

Dr. Spaide graduated from Jefferson Medical College of Thomas Jefferson University in 1981.